Why Insulin Resistance Is an Adaptive Response—At First
Paper No. 17
How a temporary change in the body's response to insulin can help redistribute energy—and why persistent resistance becomes harmful
(Estimated reading time: 6 minutes)
“A biological response that protects us under one set of conditions may become harmful when those conditions persist.” — The Tao Framework
Why Would the Body Become Resistant to Insulin?
Insulin resistance is usually described as a metabolic problem. Cells become less responsive to insulin, the pancreas produces more of it, and eventually blood glucose may begin to rise.
Over time, this can contribute to type 2 diabetes and cardiovascular disease.
But there is a question worth asking before we label every reduction in insulin sensitivity as dysfunction: why does insulin responsiveness change in the first place? The answer is that insulin sensitivity is not fixed. It changes according to nutritional state, hormonal signals, energy demand and physiological stress. During prolonged fasting, pregnancy and acute illness, certain tissues may become temporarily less responsive to insulin.
In these circumstances, reduced insulin sensitivity can help redistribute energy toward tissues with different metabolic requirements. The response may be useful precisely because the body is adapting to a changing environment.
The difficulty begins when reduced insulin sensitivity becomes persistent, particularly when accompanied by excess energy storage, altered lipid metabolism and impaired cellular signalling.

Insulin Is More Than a Blood Sugar Hormone
Insulin is often described as the hormone responsible for lowering blood glucose. Although accurate, this explanation overlooks its wider role in coordinating energy metabolism. After eating, insulin signals that nutrients are available. In skeletal muscle, it promotes glucose uptake through the movement of GLUT4 transporters to the cell membrane. In the liver, insulin suppresses glucose production and encourages glycogen synthesis. In adipose tissue, it inhibits the breakdown of stored triglycerides, reducing the release of fatty acids into circulation.
Together, these actions help the body store incoming energy and regulate how different tissues use available fuels. Between meals, insulin levels fall. The liver increases glucose output, while adipose tissue releases fatty acids that can be used by muscles and other organs.
This is a coordinated shift in fuel allocation. The body is not trying to keep insulin activity constant; it is adjusting metabolism to match circumstances.
Importantly, insulin sensitivity differs between tissues. Skeletal muscle, liver and adipose tissue do not necessarily become resistant at the same time or through identical mechanisms.
This tissue-specific behaviour is central to understanding insulin resistance.
When Insulin Resistance Serves a Physiological Purpose
During prolonged fasting, the body must preserve circulating glucose while increasing its use of stored fat. Skeletal muscle becomes more reliant on fatty acids, and its response to insulin-mediated glucose uptake may decline. This phenomenon is sometimes called physiological insulin resistance or glucose sparing. It helps conserve glucose for tissues with greater glucose requirements, although the mechanisms differ from those involved in chronic metabolic disease.
Pregnancy provides another example. During the second and third trimesters, placental hormones and other maternal adaptations progressively reduce insulin sensitivity. This helps increase nutrient availability for the developing fetus. Normally, pancreatic beta cells respond by increasing insulin secretion.
However, when that compensation is insufficient, gestational diabetes can develop. The same physiological adaptation that supports pregnancy can therefore create metabolic difficulty in susceptible individuals. Acute illness illustrates another form of altered insulin action. Infection, injury and severe physiological stress activate inflammatory pathways and increase hormones such as cortisol and catecholamines. These signals promote hepatic glucose production and can reduce insulin-mediated glucose uptake.
The resulting increase in glucose availability forms part of the body's broader stress response. Nevertheless, severe stress hyperglycaemia is not necessarily beneficial and may require active treatment. These examples demonstrate that insulin resistance is not a single biological phenomenon. Its significance depends on the tissues involved, the circumstances producing it and whether normal regulation can be restored.
How Chronic Insulin Resistance Develops
Chronic insulin resistance involves a different set of processes. One important mechanism is the accumulation of lipid intermediates in tissues that are not primarily designed for large-scale fat storage. When energy intake persistently exceeds expenditure, adipose tissue may expand. In susceptible individuals, its capacity to store additional energy safely becomes limited.
Fatty acids and lipid-derived molecules can then accumulate in the liver and skeletal muscle. Certain intermediates, including diacylglycerols and ceramides, can interfere with insulin-signalling pathways. In skeletal muscle, this can reduce insulin-stimulated glucose uptake. In the liver, insulin may become less effective at suppressing glucose production, allowing excessive glucose release despite adequate circulating insulin.
Adipose tissue dysfunction adds another layer. Enlarged fat cells, altered adipokine secretion and local immune activation can contribute to systemic insulin resistance. These processes are not identical in everyone. Genetics, physical activity, sleep, medications, hormonal conditions and patterns of fat distribution all influence metabolic susceptibility. Crucially, chronic insulin resistance is not simply a protective response that has continued for too long. It can involve genuine cellular dysfunction, altered signalling and metabolic injury.
Why the Pancreas Can Hide the Problem
When insulin-sensitive tissues respond less effectively, pancreatic beta cells often compensate by secreting more insulin. This compensation can preserve normal glucose regulation for years. A person may therefore have normal fasting glucose and HbA1c while requiring higher insulin concentrations to maintain those results.
As discussed in Paper 16, a normal glucose measurement does not always reveal the physiological effort required to achieve it. Over time, however, susceptible beta cells may struggle to maintain adequate insulin secretion relative to the degree of insulin resistance. Genetic predisposition, glucotoxicity, lipotoxicity and other metabolic stresses can contribute to progressive beta-cell dysfunction.
When compensation becomes insufficient, glucose concentrations rise more consistently, potentially progressing through prediabetes to type 2 diabetes. This progression is neither inevitable nor identical in every individual. Improvements in insulin sensitivity and metabolic health can occur before or after glucose abnormalities emerge.
Why Muscle Changes the Equation
Skeletal muscle is responsible for a substantial proportion of insulin-stimulated glucose disposal after a meal. Its metabolic activity therefore has an important influence on whole-body insulin sensitivity. Muscle contraction activates pathways that increase glucose uptake independently of insulin signalling. Exercise also improves insulin sensitivity through adaptations involving glucose transport, glycogen handling and mitochondrial oxidative capacity.
This is one reason physical activity can improve glucose regulation even when body weight changes relatively little. Conversely, prolonged inactivity reduces the repeated metabolic demands that help maintain muscle's capacity to handle glucose efficiently. Muscle is therefore not merely a site where insulin resistance develops. It is also one of the most important tissues through which insulin sensitivity can improve.
A Clinical Perspective
Understanding the distinction between physiological and pathological insulin resistance changes how we approach metabolic health. A temporary reduction in insulin sensitivity during fasting or pregnancy does not carry the same implications as persistent insulin resistance associated with visceral adiposity, hypertension, dyslipidaemia and impaired glucose regulation.
Clinical assessment should therefore consider the whole metabolic picture rather than rely on one measurement. Waist circumference, blood pressure, lipid profile, HbA1c, fasting glucose, physical activity and relevant medical history can help identify metabolic risk.
Fasting insulin may provide additional information in selected circumstances, but it is not a universally standardised diagnostic test for insulin resistance and is not routinely necessary for everyone.
For people with chronic metabolic insulin resistance, appropriately prescribed physical activity, resistance training, dietary improvement, weight reduction where indicated and treatment of contributing medical conditions can improve insulin sensitivity.
The objective is not to suppress insulin indiscriminately. Insulin is an essential hormone. The goal is to restore effective metabolic regulation.
The Tao Perspective
The Tao Framework views health as the body's ability to adapt, repair and recover as circumstances change. Insulin resistance provides an important example of why adaptation must be understood in context.
A temporary reduction in insulin sensitivity may help redistribute energy during fasting, pregnancy or physiological stress. But when insulin signalling becomes persistently impaired, the same broad pattern of reduced responsiveness can contribute to metabolic disease.
This is where Adaptive Capacity™ becomes particularly relevant. Healthy regulation requires more than the ability to activate a response. It also requires the ability to modify or reverse that response when circumstances change.
The question is not simply whether insulin sensitivity has declined, but why it has declined, whether the change is appropriate and whether the system retains the capacity to recover.
Clinical Reflection
Insulin resistance is often treated as a single abnormality. In reality, it describes a range of physiological and pathological processes that can arise for very different reasons. Sometimes reduced insulin responsiveness helps the body manage a temporary challenge. At other times, it reflects chronic metabolic stress and impaired cellular signalling.
Understanding the distinction helps us move beyond treating every biological change as inherently harmful—or assuming that every harmful change began as a useful adaptation.
The deeper lesson is that health depends not on keeping physiology constant, but on preserving the ability to respond appropriately when circumstances change.




Comments